May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
The Relationship of Statin Use to the Development of Age–Related Macular Degeneration
Author Affiliations & Notes
  • E. Friedman
    Ophthalmology, Mass Eye & Ear Infirmary, Boston, MA
  • I.K. Rigas
    Ophthalmology, Mass Eye & Ear Infirmary, Boston, MA
  • M. Makar
    Ophthalmology, Mass Eye & Ear Infirmary, Boston, MA
  • Footnotes
    Commercial Relationships  E. Friedman, None; I.K. Rigas, None; M. Makar, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 199. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. Friedman, I.K. Rigas, M. Makar; The Relationship of Statin Use to the Development of Age–Related Macular Degeneration . Invest. Ophthalmol. Vis. Sci. 2005;46(13):199.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: There is evidence that AMD is a vascular disorder, sharing epidemiologic risk factors and pathogenetic mechanisms with angiosclerosis. This raises the question of the possible protective effect of statin use on the development of AMD. Reports of the effectiveness of statins are, thus far, conflicting. Methods: 94 patients with AMD were recruited from the Retina Clinics of the Massachusetts Eye and Ear Infirmary (30 non–neovascular and 64 neovascular) along with 54 self–referred age–matched control subjects. All subjects were interviewed, their eyes examined and fundi photographed. Results: 24% of control subjects had a history of coronary artery disease compared to 36% of AMD patients (27% non–neovascular and 41% neovascular). 59% of control subjects had a history of systemic hypertension compared to 78% of AMD patients (70% non–neovascular and 81% neovascular). 45% of the control subjects used statins, compared to 25% of AMD patients (17% non–neovascular and 30% neovascular). Conclusions: Statin use is inversely related to the development of neovascular and non–neovascular AMD. An adequately powered, prospective clinical trial of statins in AMD is warranted.

Keywords: age-related macular degeneration • clinical (human) or epidemiologic studies: risk factor assessment • aging 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×